• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

工程化心肌组织

Engineering myocardial tissue.

作者信息

Eschenhagen Thomas, Zimmermann Wolfram H

机构信息

Institute of Experimental and Clinical Pharmacology, University Medical Center, Hamburg-Eppendorf, Germany.

出版信息

Circ Res. 2005 Dec 9;97(12):1220-31. doi: 10.1161/01.RES.0000196562.73231.7d.

DOI:10.1161/01.RES.0000196562.73231.7d
PMID:16339494
Abstract

To create an artificial heart is one of the most ambitious dreams of the young field of tissue engineering, a dream that, when publicly announced in 1999 (LIFE initiative around M. Sefton), provoked as much compassion as scepticism in the scientific and lay press. Today, it is fair to state that the field is still far away from having built the "bioartificial heart." Nevertheless, substantial progress has been made over the past 10 years, and a realistic perspective exists to create 3-dimensional heart muscle equivalents that may not only serve as experimental models but could also be useful for cardiac regeneration.

摘要

制造一颗人造心脏是组织工程这一新兴领域最宏伟的梦想之一。1999年(围绕M. 塞夫顿的生命计划)这一梦想公开宣布时,在科学界和大众媒体中引发了同样多的同情与质疑。如今,可以说该领域距离制造出“生物人工心脏”仍有很大差距。然而,在过去十年中已经取得了实质性进展,并且存在一种现实的前景,即制造出三维心脏肌肉等效物,其不仅可以用作实验模型,还可能对心脏再生有用。

相似文献

1
Engineering myocardial tissue.工程化心肌组织
Circ Res. 2005 Dec 9;97(12):1220-31. doi: 10.1161/01.RES.0000196562.73231.7d.
2
Creation of engineered cardiac tissue in vitro from mouse embryonic stem cells.从小鼠胚胎干细胞体外构建工程化心肌组织。
Circulation. 2006 May 9;113(18):2229-37. doi: 10.1161/CIRCULATIONAHA.105.583039. Epub 2006 May 1.
3
Heart muscle engineering: an update on cardiac muscle replacement therapy.心肌工程学:心肌替代疗法的最新进展。
Cardiovasc Res. 2006 Aug 1;71(3):419-29. doi: 10.1016/j.cardiores.2006.03.023. Epub 2006 Apr 7.
4
Cell sheet engineering for heart tissue repair.用于心脏组织修复的细胞片工程。
Adv Drug Deliv Rev. 2008 Jan 14;60(2):277-85. doi: 10.1016/j.addr.2007.08.031. Epub 2007 Oct 9.
5
Myocardial regeneration by embryonic stem cell transplantation: present and future trends.胚胎干细胞移植促进心肌再生:现状与未来趋势
Expert Rev Cardiovasc Ther. 2006 May;4(3):375-83. doi: 10.1586/14779072.4.3.375.
6
Stem cells: new cell source for myocardial constructs tissue engineering.干细胞:心肌构建组织工程的新细胞来源。
Med Hypotheses. 2006;67(6):1326-9. doi: 10.1016/j.mehy.2006.04.065. Epub 2006 Jul 11.
7
Endogenous cardiac stem cells.内源性心脏干细胞
Prog Cardiovasc Dis. 2007 Jul-Aug;50(1):31-48. doi: 10.1016/j.pcad.2007.03.005.
8
Heart repair and stem cells.心脏修复与干细胞
J Physiol. 2006 Dec 1;577(Pt 2):467-78. doi: 10.1113/jphysiol.2006.115816. Epub 2006 Sep 28.
9
Myocardial tissue engineering: the extracellular matrix.心肌组织工程:细胞外基质
Eur J Cardiothorac Surg. 2008 Aug;34(2):229-41. doi: 10.1016/j.ejcts.2008.03.062. Epub 2008 May 27.
10
Cell sources for cardiovascular tissue regeneration and engineering.用于心血管组织再生与工程的细胞来源。
Thorac Cardiovasc Surg. 2009 Mar;57(2):63-73. doi: 10.1055/s-2008-1039235. Epub 2009 Feb 24.

引用本文的文献

1
Exploring hiPSC-CM replacement therapy in ischemic hearts.探索人诱导多能干细胞来源的心肌细胞在缺血性心脏中的替代疗法。
Basic Res Cardiol. 2025 Jun 10. doi: 10.1007/s00395-025-01117-w.
2
Cardiac Tissue Engineering for Translational Cardiology: From In Vitro Models to Regenerative Therapies.用于转化心脏病学的心脏组织工程:从体外模型到再生疗法
Bioengineering (Basel). 2025 May 14;12(5):518. doi: 10.3390/bioengineering12050518.
3
Model construction and clinical therapeutic potential of engineered cardiac organoids for cardiovascular diseases.
用于心血管疾病的工程化心脏类器官的模型构建及临床治疗潜力
Biomater Transl. 2024 Nov 15;5(4):337-354. doi: 10.12336/biomatertransl.2024.04.002. eCollection 2024.
4
MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review.微小RNA生物标志物作为神经退行性疾病的下一代诊断工具:综述
Front Mol Neurosci. 2024 May 31;17:1386735. doi: 10.3389/fnmol.2024.1386735. eCollection 2024.
5
Advances in 3D Bioprinted Cardiac Tissue Using Stem Cell-Derived Cardiomyocytes.基于干细胞衍生心肌细胞的 3D 生物打印心脏组织的研究进展。
Stem Cells Transl Med. 2024 May 14;13(5):425-435. doi: 10.1093/stcltm/szae014.
6
Geometry and length control of 3D engineered heart tissues using direct laser writing.使用直接激光写入技术对3D工程心脏组织进行几何形状和长度控制。
Lab Chip. 2024 Mar 12;24(6):1685-1701. doi: 10.1039/d3lc00752a.
7
Proliferation and Maturation: Janus and the Art of Cardiac Tissue Engineering.增殖与成熟:两面神与心脏组织工程的艺术。
Circ Res. 2023 Feb 17;132(4):519-540. doi: 10.1161/CIRCRESAHA.122.321770. Epub 2023 Feb 16.
8
Bizonal cardiac engineered tissues with differential maturation features in a mid-throughput multimodal bioreactor.在中通量多模态生物反应器中具有不同成熟特征的双区心脏工程组织。
iScience. 2022 Apr 26;25(5):104297. doi: 10.1016/j.isci.2022.104297. eCollection 2022 May 20.
9
Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease.心脏类器官:用于模拟心脏发育和疾病的 3D 技术。
Stem Cell Rev Rep. 2022 Dec;18(8):2593-2605. doi: 10.1007/s12015-022-10385-1. Epub 2022 May 8.
10
Cardiac Organoids to Model and Heal Heart Failure and Cardiomyopathies.用于模拟和治疗心力衰竭及心肌病的心脏类器官
Biomedicines. 2021 May 18;9(5):563. doi: 10.3390/biomedicines9050563.